Diagnostic antibodies and antigens for pain-related acetaminophen (Paracetamol) toxicity testing
Acetaminophen is known as paracetamol in many countries outside the US. It is one of the most frequently used oral analgesics and antipyretics. It has an outstanding safety profile when administered in an appropriate dose, but hepatotoxicity can occur after overdose or when misused in at-risk populations. GENEMEDI developed the antigens and antibodies for the diagnosis of potential acetaminophen toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
|Cat No.||Species||Biomarker||Disease||Cat No.of Antigen||Bioactivity validation of Antigen||Cat No.of Antibodies||Bioactivity validation of Antibodies||Order|
|Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-acetaminophen (Paracetamol)], acetaminophen (Paracetamol) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation.||GMP-SMT-Paracetamol-Ab01:
Anti-acetaminophen (Paracetamol) mouse monoclonal antibody(mAb)
|Human acetaminophen (Paracetamol) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation.|